ENDONOVO THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $15.6M | $4.2M | $379.2K |
| FY2019 | $23.8M | $3.3M | $18.9K |
| FY2020 | $17.0M | $2.6M | $13.4K |
| FY2021 | $17.8M | $2.0M | $85.9K |
| FY2022 | $33.5M | $1.3M | — |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $15.6M | $4.2M | $379.2K |
| FY2019 | $23.8M | $3.3M | $18.9K |
| FY2020 | $17.0M | $2.6M | $13.4K |
| FY2021 | $17.8M | $2.0M | $85.9K |
| FY2022 | $33.5M | $1.3M | — |